Home Prostate / Prostate Cancer BRIEF-Exelixis Announces Initiation Of Phase 3 Pivotal Trial For Previously Treated Metastatic...

BRIEF-Exelixis Announces Initiation Of Phase 3 Pivotal Trial For Previously Treated Metastatic Castration-Resistant Prostate Cancer

21
0

June 30 (Reuters) – Exelixis Inc:

* EXELIXIS ANNOUNCES INITIATION OF CONTACT-02 PHASE 3 PIVOTAL TRIAL OF CABOZANTINIB IN COMBINATION WITH ATEZOLIZUMAB IN PREVIOUSLY TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

* EXELIXIS INC – CONTACT-02 IS SECOND OF THREE PHASE 3 PIVOTAL TRIALS THAT ARE PART OF A CLINICAL COLLABORATION WITH ROCHE

* EXELIXIS INC – INITIATION FOLLOWS POSITIVE RESULTS FROM COHORT 6 OF PHASE 1B COSMIC-021 TRIAL

* EXELIXIS INC – CO-PRIMARY ENDPOINTS OF CONTACT-02 TRIAL ARE PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL Source text for Eikon: Further company coverage:

https://www.reuters.com/article/brief-exelixis-announces-initiation-of-p/brief-exelixis-announces-initiation-of-phase-3-pivotal-trial-for-previously-treated-metastatic-castration-resistant-prostate-cancer-idUSASA00VDQ

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.